Three variants associated with NSCLC were amplified in a multiplex PCR; including one ERBB2 exon 17 substitution, one ERBB2 exon 20 insertion, and one EML4-ALK fusion. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.